Effect of taurine, L-cysteic and orthanilic acids on cardiac tension.
Franconi
F
F
Dep. Pharmacology, University of Florence, Italy.
Bennardini
F
F
Campana
S
S
Failli
P
P
Matucci
R
R
Stendardi
I
I
Giotti
A
A
D000818:Animals; D002122:Calcium Chloride / Q000494:pharmacology; D002927:Cimetidine / Q000494:pharmacology; D003544:Cysteic Acid / Q000494:pharmacology*; D004347:Drug Interactions; D005711:Gallopamil / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013425:Sulfanilic Acids / Q000494:pharmacology*; D013654:Taurine / Q000494:pharmacology*; D015091:beta-Alanine / Q000494:pharmacology
D013425:Sulfanilic Acids; D015091:beta-Alanine; D013654:Taurine; D010656:Phenylephrine; D005711:Gallopamil; D002927:Cimetidine; D011433:Propranolol; D003544:Cysteic Acid; D007545:Isoproterenol; D002122:Calcium Chloride; D007213:Indomethacin; D010646:Phentolamine; C100048:2-sulfanilic acid